Goldberg Andrew D. (0001827722)

Mailing Address 15440 LAGUNA CANYON ROAD, SUITE 160 IRVINE CA 92618 Ownership Reports for Issuers: (Click on issuer name to see other owners for the issuer, or CIK for issuer filings.) Issuer Filings Transaction Date Type of Owner Tarsus Pharmaceuticals, Inc. 0001819790 2020-10-15 director

Items 1 - 16

The information presented below contains only portions of the information presented in the referenced filing or filings.
You should consult the original filing for complete information. Hyperlinks to the forms are provided for your convenience.

Acquistion or Disposition	Transaction Date	Deemed Execution Date	Issuer	Form	Transaction Type	Direct or Indirect Ownership	Number of Securities Transacted	Number of Securities Owned	Line Number	Issuer CIK	Security Name
A	2025-03-07		Tarsus Pharmaceuticals, Inc.	4	M-Exempt	--D	7000.0000	13350.0000	1	0001819790	Common Stock
D	2025-03-07		Tarsus Pharmaceuticals, Inc.	4	M-Exempt	--D	7000.0000	0.0000	2	0001819790	Stock Option (right to buy)
A	2024-06-24		Tarsus Pharmaceuticals, Inc.	4	M-Exempt	--D	3350.0000	6350.0000	1	0001819790	Common Stock
D	2024-06-24		Tarsus Pharmaceuticals, Inc.	4	M-Exempt	--D	3350.0000	0.0000	2	0001819790	Restricted Stock Units
A	2024-06-13		Tarsus Pharmaceuticals, Inc.	4	A-Award	--D	5000.0000	5000.0000	1	0001819790	Stock Option (right to buy)
A	2024-06-13		Tarsus Pharmaceuticals, Inc.	4	A-Award	--D	3350.0000	3350.0000	2	0001819790	Restricted Stock Units
A	2023-12-15		Tarsus Pharmaceuticals, Inc.	4	P-Purchase	--D	1000.0000	3000.0000	1	0001819790	Common Stock
A	2023-06-22		Tarsus Pharmaceuticals, Inc.	4	A-Award	--D	5000.0000	5000.0000	1	0001819790	Stock Option (right to buy)
A	2023-06-22		Tarsus Pharmaceuticals, Inc.	4	A-Award	--D	3350.0000	3350.0000	2	0001819790	Restricted Stock Units
A	2023-06-16		Tarsus Pharmaceuticals, Inc.	4	M-Exempt	--D	2000.0000	2000.0000	1	0001819790	Common Stock
D	2023-06-16		Tarsus Pharmaceuticals, Inc.	4	M-Exempt	--D	2000.0000	0.0000	2	0001819790	Restricted Stock Units
A	2022-06-16		Tarsus Pharmaceuticals, Inc.	4	A-Award	--D	7000.0000	7000.0000	1	0001819790	Stock Option (right to buy)
A	2022-06-16		Tarsus Pharmaceuticals, Inc.	4	A-Award	--D	2000.0000	2000.0000	2	0001819790	Restricted Stock Units
A	2021-06-15		Tarsus Pharmaceuticals, Inc.	4	A-Award	--D	7500.0000	7500.0000	1	0001819790	Stock Option (right to buy)
A	2021-06-15		Tarsus Pharmaceuticals, Inc.	4	A-Award	--D	10000.0000	10000.0000	2	0001819790	Stock Option (right to buy)
-	-		Tarsus Pharmaceuticals, Inc.	3	-	---			1	-	-

http://www.sec.gov/cgi-bin/own-disp

---